Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H van Hooff

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of Assisted Reproduction and Genetics|April 1, 1995
The human menopausal gonadotropin (hMG) dose in in vitro fertilization (IVF): what is the optimal dose?M H van Hooff
Fertility and Sterility|July 1, 1993
Statistical rubato and confidence intervalsC B Lambalk, M H van Hooff
Lancet (London, England)|February 11, 1998
Length of gestation and polycystic ovaries in adulthoodM H van Hooff, C B Lambalk
Nederlands Tijdschrift Voor Geneeskunde|March 25, 2004
[Diagnostic image (178). A term pregnant woman with a tumor in the vulva. Extreme edematous swelling of the anterior labium of the cervix]M R de Jonker, M H van Hooff
Andrologia|January 7, 2014
Effect of total motile sperm count in intra-uterine insemination on ongoing pregnancy rateM Kleppe, M H van Hooff, J P Rhemrev
Human Reproduction (Oxford, England)|July 13, 1999
Variation of luteinizing hormone and androgens in oligomenorrhoea and its implications for the study of polycystic ovary syndromeM H van Hooff, M van der Meer, C B Lambalk, et al.
Human Reproduction (Oxford, England)|March 25, 1998
Treatment of hyperinsulinaemia in polycystic ovary syndrome?J M van Montfrans, M H van Hooff, P G Hompes, et al.
Human Reproduction (Oxford, England)|June 2, 2001
Are elevated FSH concentrations in the pre-conceptional period a risk factor for Down's syndrome pregnancies?J M van Montfrans, C B Lambalk, M H van Hooff, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 28, 1995
[Use of the pill by adolescents for contraception or as therapy]M H van Hooff, R A Hirasing, M Kaptein, et al.
Human Reproduction (Oxford, England)|March 1, 1993
Doubling the human menopausal gonadotrophin dose in the course of an in-vitro fertilization treatment cycle in low responders: a randomized studyM H van Hooff, A T Alberda, G J Huisman, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Assisted Reproduction and Genetics|April 1, 1995
The human menopausal gonadotropin (hMG) dose in in vitro fertilization (IVF): what is the optimal dose?M H van Hooff
Fertility and Sterility|July 1, 1993
Statistical rubato and confidence intervalsC B Lambalk, M H van Hooff
Lancet (London, England)|February 11, 1998
Length of gestation and polycystic ovaries in adulthoodM H van Hooff, C B Lambalk
Nederlands Tijdschrift Voor Geneeskunde|March 25, 2004
[Diagnostic image (178). A term pregnant woman with a tumor in the vulva. Extreme edematous swelling of the anterior labium of the cervix]M R de Jonker, M H van Hooff
Andrologia|January 7, 2014
Effect of total motile sperm count in intra-uterine insemination on ongoing pregnancy rateM Kleppe, M H van Hooff, J P Rhemrev
Human Reproduction (Oxford, England)|July 13, 1999
Variation of luteinizing hormone and androgens in oligomenorrhoea and its implications for the study of polycystic ovary syndromeM H van Hooff, M van der Meer, C B Lambalk, et al.
Human Reproduction (Oxford, England)|March 25, 1998
Treatment of hyperinsulinaemia in polycystic ovary syndrome?J M van Montfrans, M H van Hooff, P G Hompes, et al.
Human Reproduction (Oxford, England)|June 2, 2001
Are elevated FSH concentrations in the pre-conceptional period a risk factor for Down's syndrome pregnancies?J M van Montfrans, C B Lambalk, M H van Hooff, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 28, 1995
[Use of the pill by adolescents for contraception or as therapy]M H van Hooff, R A Hirasing, M Kaptein, et al.
Human Reproduction (Oxford, England)|March 1, 1993
Doubling the human menopausal gonadotrophin dose in the course of an in-vitro fertilization treatment cycle in low responders: a randomized studyM H van Hooff, A T Alberda, G J Huisman, et al.
Pageof 2